Jamie Y Hur, D.O.
National Heart, Lung, and Blood Institute (NHLBI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jamie Y Hur, D.O. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:36 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05509582 · Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated CytopeniasNational Heart, Lung, and Blood Institute (NHLBI) · withdrawn · Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD · principal investigator
- Ph2NCT05502783 · Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated CytopeniasNational Heart, Lung, and Blood Institute (NHLBI) · terminated · Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.